| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.075 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |